Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial
Article
Mehta, MP, Gervais, R, Chabot, P et al. (2006). Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial
. JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 7014-7014. 10.1200/jco.2006.24.18_suppl.7014
Mehta, MP, Gervais, R, Chabot, P et al. (2006). Motexafin gadolinium (MGd) combined with prompt whole brain radiation therapy (RT) prolongs time to neurologic progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a phase III trial
. JOURNAL OF CLINICAL ONCOLOGY, 24(18_suppl), 7014-7014. 10.1200/jco.2006.24.18_suppl.7014